Quality and regulatory programs have historically functioned as a cost center for manufacturers of medical devices, pharmaceuticals and other regulated industries. In this webcast, you will learn how to view the vital missions of these quality and regulatory business units as a central strategic initiative that drives new product introduction and expansion to build market leadership.
The aim is to offer a better understanding of the synergy between quality and regulatory activities in product development, risk management, problem-solving, kaizens and quality analytics. Fully grasping this relationship will help to foster a culture of continuous improvement and to transform quality and regulatory programs into important profit drivers.
The webcast will conclude with lessons learned from the COVID-19 pandemic about leveraging risk management and quality management systems to maximize business success in times of disruption and digital transformation.
In this webinar, you’ll learn:
Speakers:
Kathy Lease, QA/RA Systems Administrator, Tecomet has been an employee of Tecomet, a leading provider of precision manufacturing solutions for the Medical Device and Aerospace & Defense markets, for 29 years. Currently, she is the companies’ sole ETQ Reliance System Administrator, a role she has held for the past 10 years. Prior, she worked as a Quality / Packaging Engineer and held roles in Manufacturing, Scheduling and Programming. Kathy also holds a Bachelors degree in Computer Information Systems.
Michel Moravia, Product Manager, Quality, ETQ is a quality leader and engineering professional with over 10 years of experience in the biotech and medical device industries. His expertise spans new product introduction, quality control/quality assurance, and technology and manufacturing transfer. He has served as a leader for PSP courses and kaizens for Danaher Corporation and is a certified BSI ISO 13485: 2016 Lead Auditor. Michel holds a Masters of Science in product design engineering and an MBA from Boston University.